NCI-H1522 [H1522]
NCI-H1522 [H1522]
规格:
货期:
编号:TS167582
品牌:Testobio
| 产品名称： | NCI-H1522 H1522 |
|---|---|
| 商品货号： | TS167582 |
| Organism： | Homo sapiens, human |
| Tissue： | lung |
| Product Format： | flask |
| Morphology： | rounded |
| Culture Properties： | mixed adherent-suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | stage E,carcinoma; small cell lung cancer |
| Age： | 53 years |
| Gender： | male |
| Ethnicity： | Caucasian |
| Applications： | The line was established in October 1986. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Derivation： | The line was established in October 1986. |
| Clinical Data： | The patient received prior chemotherapy and radiation therapy. The patient was a smoker. male Caucasian 53 years |
| Comments： | The line was established in October 1986. The patient received prior chemotherapy and radiation therapy. The patient was a smoker. 60 pack years. |
| Complete Growth Medium： | HITES medium supplemented with 5% fetal bovine serum
|
| Cryopreservation： | Culture medium, 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C |
| STR Profile： | Amelogenin: XY CSF1PO: 10 D13S317: 12 D16S539: 11 D5S818: 11 D7S820: 9, 11, 12 THO1: 7, 9.3 TPOX: 8, 11 vWA: 17, 20 |
| Name of Depositor： | AF Gazdar, JD Minna |
| Deposited As： | Homo sapiens |
| Year of Origin： | 1986 |
| References： | NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
NCI-H1522 [H1522]
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | NCI-H1522 H1522 |
|---|---|
| 商品货号： | TS167582 |
| Organism： | Homo sapiens, human |
| Tissue： | lung |
| Product Format： | flask |
| Morphology： | rounded |
| Culture Properties： | mixed adherent-suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | stage E,carcinoma; small cell lung cancer |
| Age： | 53 years |
| Gender： | male |
| Ethnicity： | Caucasian |
| Applications： | The line was established in October 1986. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Derivation： | The line was established in October 1986. |
| Clinical Data： | The patient received prior chemotherapy and radiation therapy. The patient was a smoker. male Caucasian 53 years |
| Comments： | The line was established in October 1986. The patient received prior chemotherapy and radiation therapy. The patient was a smoker. 60 pack years. |
| Complete Growth Medium： | HITES medium supplemented with 5% fetal bovine serum
|
| Cryopreservation： | Culture medium, 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C |
| STR Profile： | Amelogenin: XY CSF1PO: 10 D13S317: 12 D16S539: 11 D5S818: 11 D7S820: 9, 11, 12 THO1: 7, 9.3 TPOX: 8, 11 vWA: 17, 20 |
| Name of Depositor： | AF Gazdar, JD Minna |
| Deposited As： | Homo sapiens |
| Year of Origin： | 1986 |
| References： | NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. |
